oncology management

Research in Review

New NGS Platform Better Identifies Targetable Genomic Alterations in Metastatic Cancers

05/31/2017

JCP Editors

A new comprehensive next generation sequencing (NGS) platform is more likely than targeted NGS platforms to identify clinically relevant and actionable molecular alterations in metastatic cancers, according to...

A new...

05/31/2017

Journal of Clinical Pathways

Research in Review

Integration of Palliative Care in Oncology Improves Outcomes and Reduces Spending

05/15/2017

JCP Editors

Mount Sinai’s Icahn School of Medicine (New York, NY) provides a model for adopting palliative care practices into their solid tumor oncology service that results in significant increases in hospice referrals and...

Mount...

05/15/2017

Journal of Clinical Pathways

Research in Review

PRO Survey Easily Integrated Into Standard Oncology Practice

03/15/2017

JCP Editors

Patient-reported outcomes (PROs) can be introduced to both general and academic oncology practices through the use of standardized reporting tools, such as the revised Edmonton Symptom Assessment Scale (ESAS-r),...

...

03/15/2017

Journal of Clinical Pathways

Interview

Clinical Pathways in Community Oncology: Assessing the Work of the American Society of Clinical Oncology Task Force on Clinical Pathways

02/13/2017

JCP Editors

Providers and practices across medical specialties have eagerly adopted clinical pathways in efforts to standardize care and achieve uniform outcomes. However, few disciplines have been as receptive to the concept of...

...

02/13/2017

Journal of Clinical Pathways

Research in Review

Five-Tiered Gleason Grade Grouping System Accurately Predicts Prostate Cancer-Specific Mortality

01/20/2017

JCP Editors

A population-based study recently validated the five-tiered Gleason Grade Grouping system for predicting mortality among patients with prostate cancer, published in European Urology. Clinicians have used the Gleason...

A...

01/20/2017

Journal of Clinical Pathways

Research in Review

Precision Medicine Increasingly Guides Decision-Making for Patients with Breast Cancer

12/29/2016

JCP Editors

Breast cancer serves as a model for using precision medicine to guide treatment decisions and improve patients’ quality of life, according to a presentation at the 2016 Lynn Sage Breast Cancer...

Breast...

12/29/2016

Journal of Clinical Pathways

Research in Review

Insurance Expansion Improves Resection Rates Among Patients with Colorectal Cancer

12/13/2016

JCP Editors

The implementation of health care reform in Massachusetts increased surgical resection rates for colorectal cancer and decreased the likelihood of emergent resection, suggesting that insurance expansion may improve...

The...

12/13/2016

Journal of Clinical Pathways

Research in Review

NET Equally Effective, Safer Than Neoadjuvant Chemotherapy for ER+ Breast Cancer

11/11/2016

JCP Editors

Neoadjuvant endocrine therapy may be just as effective as neoadjuvant chemotherapy for patients with localized, estrogen-receptor (ER)-positive breast cancer with considerably fewer adverse events, according to a...

...

11/11/2016

Journal of Clinical Pathways

Quiz

Best Targeted Therapy for Melanoma

11/10/2016

JCP Editors

A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...

A...

11/10/2016

Journal of Clinical Pathways

Research in Review

Primary Prophylaxis for Breast Cancer Offers Little Benefit

11/07/2016

JCP Editors

The use of white blood cell growth stimulating factor drugs to reduce risk of neutropenia-related complications in women with breast cancer receiving common first-cycle chemotherapies had only a low-to-modest benefit...

The...

11/07/2016

Journal of Clinical Pathways